Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers (Q36696902)
Jump to navigation
Jump to search
scientific article published on March 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers |
scientific article published on March 2004 |
Statements
1 reference
Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers (English)
1 reference
J B Bartlett
1 reference
A Michael
1 reference
I A Clarke
1 reference
K Dredge
1 reference
S Nicholson
1 reference
H Kristeleit
1 reference
A Polychronis
1 reference
H Pandha
1 reference
G W Muller
1 reference
D I Stirling
1 reference
J Zeldis
1 reference
A G Dalgleish
1 reference
1 March 2004
1 reference
1 reference
955-961
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference